President and CEO
Mr. Daniel serves as Chief Executive Officer and President of CCI, primarily responsible for strategic planning, business and market development, and worldwide sales. His most recent previous business experience was Vice President of Sales and Marketing for Myelotec, Inc., a medical device manufacturing company. Prior to Myelotec, Mr. Daniel was the Vice President of Market Development for Spheringenics, Inc., – a stem cell research company that licensed technology developed at the Georgia Institute of Technology (Georgia Tech). Mr. Daniel also was previously President of Allograft Solutions, Inc., a company that procured, banked, and distributed tissue donations.
Tom Barrows, PhD
Executive Vice President and CSO
Dr. Barrows is responsible for operations and research and is the inventor of CCI’s biomaterials technology. His career in biomedical materials research began after obtaining a PhD in organic chemistry from The Pennsylvania State University and includes 22 years at 3M where he invented and developed bioabsorbable polymers and surgical devices including tissue sealants. He was recruited to join a start-up venture in the Boston area in 1996 to continue research on tissue sealants. From there he relocated to Atlanta, GA and co-founded BioAmide, Inc. and began applying tissue engineering principles to the development of solutions for hair restoration, which led to the acquisition of BioAmide in 2002 by Bosley/Aderans (Aderans, Ltd., Tokyo, Japan) and simultaneous formation of the Aderans Research Institute, Inc. (ARI). In 2008 he left ARI and co-founded CCI with the goal of utilizing stem cells to cure chronic wounds.
Chris Ingraham, PhD
Director of Research and Development
Dr. Ingraham joined CCI in 2013 and is currently responsible for cell culture research and product development. After obtaining a B.S. degree from the Rochester Institute of Technology he began working as a cell biologist at the University of Rochester on mitochondrial diseases where he received his Ph.D. in 2007. Subsequently his research focused on the technology of stem cell culture conditions and he continued this work at The Scripps Research Institute in La Jolla, CA. In 2011, Dr. Ingraham entered the field of cell-based hair restoration product development as a Senior Scientist at the Aderans Research Institute in Marietta, GA. His professional goal is aligned with the vision of CCI: to become a pioneer in the field of human cell regenerative therapy.